Mark J. Ernsting
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 19
- Nanoparticle-Based Drug Delivery 17
-
- Nanoplatforms for cancer theranostics 10
- Co-authors
- Shyh‐Dar Li (19 shared papers)Mami Murakami (5 shared papers)Aniruddha Roy (5 shared papers)Tatsuaki Tagami (6 shared papers)Elijus Undzys (10 shared papers)Jonathan P. May (5 shared papers)Warren D. Foltz (3 shared papers)Wei-Lun Tang (2 shared papers)
- Journals
- Biomaterials (6 papers)Journal of Controlled Release (6 papers)Molecular Pharmaceutics (3 papers)Bioconjugate Chemistry (2 papers)The Journal of Strength and Conditioning Research (2 papers)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Mark J. Ernsting
36 papers receiving 2.4k citations
Mark J. Ernsting's Hit Papers
Peers
Comparison fields: 5 of 121
- Biomaterials 1.4k
- Pharmaceutical Science 166
- Biomedical Engineering 1.2k
- Molecular Medicine 80
- Oncology 294
Countries citing papers authored by Mark J. Ernsting
This map shows the geographic impact of Mark J. Ernsting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Ernsting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Ernsting more than expected).
Fields of papers citing papers by Mark J. Ernsting
This network shows the impact of papers produced by Mark J. Ernsting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Ernsting. The network helps show where Mark J. Ernsting may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark J. Ernsting, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles Hit paper breakdown → | 2013 | 832 |
| 2 | 2011 | 165 | |
| 3 | 2011 | 131 | |
| 4 | 2011 | 126 | |
| 5 | 2015 | 115 | |
| 6 | 2013 | 111 | |
| 7 | 2011 | 96 | |
| 8 | 2012 | 84 | |
| 9 | 2011 | 82 | |
| 10 | 2007 | 80 | |
| 11 | 2012 | 76 | |
| 12 | 2015 | 71 | |
| 13 | 2015 | 67 | |
| 14 | 2012 | 46 | |
| 15 | 2013 | 41 | |
| 16 | 2014 | 40 | |
| 17 | 2017 | 38 | |
| 18 | 2014 | 37 | |
| 19 | 2017 | 32 | |
| 20 | 2005 | 30 |
About Mark J. Ernsting
Mark J. Ernsting is a scholar working on Biomaterials, Biomedical Engineering, Oncology, Surgery and Molecular Biology, having authored 36 papers that have together received 2.4k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (17 papers), Nanoplatforms for cancer theranostics (10 papers), Cancer Treatment and Pharmacology (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Polymer Surface Interaction Studies (2 papers), Neuroscience and Neuropharmacology Research (2 papers), RNA Interference and Gene Delivery (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Biomaterials (1.4k citations), Pharmaceutical Science (166 citations), Biomedical Engineering (1.2k citations), Molecular Medicine (80 citations) and Oncology (294 citations). Mark J. Ernsting has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Shyh‐Dar Li, Mami Murakami, Aniruddha Roy, Tatsuaki Tagami, Elijus Undzys, Jonathan P. May, Warren D. Foltz, Wei-Lun Tang, Bryan Hoang and Carol Lee. Their work appears in journals such as Biomaterials, Journal of Controlled Release, Molecular Pharmaceutics, Bioconjugate Chemistry and The Journal of Strength and Conditioning Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.